Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
17.06.24
/
50%
€974.20
Target price
17.06.25
€1,072.3
Performance (%)
-54.45%
End price
18.06.25
€443.70
Summary
This prediction ended on 18.06.25 with a price of €443.70. The BUY prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -54.45%. JPMorgan_Chase___Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.129% | 0.129% | -16.036% |
| iShares Core DAX® | 1.803% | 0.496% | 18.553% |
| iShares Nasdaq 100 | 0.429% | -0.410% | 8.908% |
| iShares Nikkei 225® | 0.708% | -3.799% | 12.088% |
| iShares S&P 500 | 0.288% | -0.218% | 3.736% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at JPMorgan Chase & Co. from $1,050.00 to $1,150.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€586.00
31.03.25
31.03.25
€922.40
31.03.26
31.03.26
6.42%
10.12.25
10.12.25
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.50
09.06.25
09.06.25
€700.56
09.06.26
09.06.26
40.10%
10.12.25
10.12.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,099.6
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25